Pain

Quantity of Opioids Prescribed Postop Linked to Consumption

Quantity of Opioids Prescribed Postop Linked to Consumption

The quantity of opioids prescribed after surgery is associated with patient-reported opioid consumption.

US Opioid Overdose Deaths Reach Record Number

US Opioid Overdose Deaths Reach Record Number

The number of opioid overdose deaths in the United States reached a new record last year with 72,000 deaths, which works out to about 200 a day.

FDA Approves Powerful New Opioid Despite Criticisms

FDA Approves Powerful New Opioid Despite Criticisms

Ruling against the recommendation of one of its chief experts, the US FDA approved an extremely potent new opioid painkiller, Dsuvia.

Opioid Use Often Persists in Workers' Compensation Claimants

Opioid Use Often Persists in Workers' Compensation Claimants

Many patients in a workers' compensation cohort have persistent opioid use.

Benefits of a Pain and Stress Management Program for the Management of Chronic Pain

Benefits of a Pain and Stress Management Program for the Management of Chronic Pain

By

A "Pain and Stress Management" program for the management of chronic pain, was found to be effective in alleviating pain, diminishing stress, promoting self-management of pain, and ameliorating general well-being.

Bill to Fight US Opioid Crisis Signed Into Law

Bill to Fight US Opioid Crisis Signed Into Law

A bipartisan bill meant to combat the United States' opioid abuse epidemic was signed into law October 24 by President Donald Trump.

ASA: Dorsal Root Ganglion Stimulation Disrupts Back Pain

ASA: Dorsal Root Ganglion Stimulation Disrupts Back Pain

Dorsal root ganglion neurostimulation therapy may reduce pain and disability in patients with chronic lower extremity and back pain.

FDA Panel Votes on Drug/Device Combo to Treat Pain in Medically Supervised Setting

FDA Panel Votes on Drug/Device Combo to Treat Pain in Medically Supervised Setting

By

The FDA is not bound by the Committee's recommendation but takes it into consideration when making its decision.

Risk of Opioid-Benzodiazepine Overlap Up for Dual Prescribing

Risk of Opioid-Benzodiazepine Overlap Up for Dual Prescribing

Receiving prescriptions from both the US Department of Veterans Affairs and Medicare Part D is associated with increased risk for overlapping of opioid and benzodiazepine prescriptions.

Congress Passes Bill to Fight Opioid Crisis

Congress Passes Bill to Fight Opioid Crisis

A bipartisan bill to fight the opioid addiction crisis in the United States has been passed by Congress.

Opioid Use Down With 'Enhanced Recovery After Surgery' Program

Opioid Use Down With 'Enhanced Recovery After Surgery' Program

An "enhanced recovery after surgery" program is associated with a significant reduction in opioid consumption after gynecologic surgery with no increase in pain scores.

Opioid Bill Gets Bipartisan Support

Opioid Bill Gets Bipartisan Support

In a rare bipartisan move, both the House and Senate have reached a compromise on legislation to address the opioid epidemic.

Potentially Inappropriate Opioid Prescribing Tied to Overdose

Potentially Inappropriate Opioid Prescribing Tied to Overdose

Potentially inappropriate prescribing (PIP) of opioids is associated with increased risk of all-cause mortality and fatal and nonfatal overdose.

FDA: Opioid Analgesic REMS Expanded to Include Immediate-Release Products

FDA: Opioid Analgesic REMS Expanded to Include Immediate-Release Products

By

As part of the REMS program, drug companies with approved opioid analgesics must make training available to prescribers and provide unrestricted grants to accredited continuing education providers for the development of education courses.

CDC: About One in Five U.S. Adults Have Chronic Pain

CDC: About One in Five U.S. Adults Have Chronic Pain

About 20.4% of US adults have chronic pain and 8.0% have high-impact chronic pain.

Opioids Often Prescribed in the Absence of Pain Diagnosis

Opioids Often Prescribed in the Absence of Pain Diagnosis

Many outpatient opioid prescriptions have no documented medical indication.

Chronic Pain May Be Contributor to Suicide

Chronic Pain May Be Contributor to Suicide

Chronic pain may be an important contributor to suicide, with 8.8 percent of suicide decedents having evidence of chronic pain.

Oxycontin's Maker Now Selling Drug to Curb Opioid Addiction

Oxycontin's Maker Now Selling Drug to Curb Opioid Addiction

Purdue Pharma, the maker of Oxycontin who some have blamed for the epidemic of opioid painkiller addictions, has patented a medicine aimed at curbing those disorders.

With New Persistent Opioid Use, Most Early Scripts From Surgeons

With New Persistent Opioid Use, Most Early Scripts From Surgeons

Among surgical patients who develop new persistent opioid use, surgeons provide the majority of opioid prescriptions in the first few months after surgery.

Opioid Maker to Pay for Overdose Antidote Development

Opioid Maker to Pay for Overdose Antidote Development

A $3.4 million grant to help a non-profit company develop a less expensive opioid overdose antidote was announced by Purdue Pharma, which makes the opioid painkiller OxyContin.

Pregabalin may increase the risk of death when coprescribed with opioids

Patients coprescribed opioids and pregabalin had significantly increased odds of opioid-related death compared to opioid prescription alone.

FDA Outlines Plan for New Analgesic Guidance to Combat Opioid Crisis

FDA Outlines Plan for New Analgesic Guidance to Combat Opioid Crisis

By

The new plan will break out the current guidance into 4 separate guidances.

US Opioid Use Not Declining, Despite Focus on Abuse

US Opioid Use Not Declining, Despite Focus on Abuse

Rates of opioid use in the United States do not appear to be declining.

FDA Warning Letters Target Illegal Online Sales of Opioids

FDA Warning Letters Target Illegal Online Sales of Opioids

Four more online networks that operate 21 websites illegally selling potentially dangerous, unapproved, and misbranded versions of opioid pain medications have been told to immediately stop their sales.

Odds of Death Up With Exposure to Pregabalin, Opioids

Odds of Death Up With Exposure to Pregabalin, Opioids

Concomitant exposure to pregabalin and opioids is associated with increased odds of opioid-related death.

DEA Proposal Will Significantly Cut Opioid Manufacturing in 2019

DEA Proposal Will Significantly Cut Opioid Manufacturing in 2019

By

Last year, the DEA proposed a 20% reduction in the manufacturing of controlled substances for 2018 compared to 2017.

Transdermal Buprenorphine Not Well Tolerated in Dementia

Transdermal Buprenorphine Not Well Tolerated in Dementia

By

The researchers conducted a 13-week study that included 162 individuals with advanced dementia and considerable depression residing in nursing homes in Norway.

White Matter Hyperintensities Demonstrate Specific Spatiotemporal Evolution in Reversible Cerebral Vasoconstriction Syndrome

White Matter Hyperintensities Demonstrate Specific Spatiotemporal Evolution in Reversible Cerebral Vasoconstriction Syndrome

By

The characteristics of white matter hyperintensities were assessed to provide information on the underlying mechanisms of these lesions in individuals with reversible cerebral vasoconstriction syndrome.

Co-Prescription of Opioids and Antidepressants Prevalent in Migraine

Co-Prescription of Opioids and Antidepressants Prevalent in Migraine

By

Researchers sought to assess the prevalence of concomitant prescribing of opioid analgesics with a triptan or a serotogeneric antidepressant in individuals with migraine.

Anticonvulsants Seem to Be Ineffective for Low Back Pain

Anticonvulsants Seem to Be Ineffective for Low Back Pain

Anticonvulsant drugs are ineffective for chronic low back pain and can cause harm, despite a recent increase in prescribing.

Sign Up for Free e-newsletters



CME Focus